MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647128122 A) filed by Ractigen Therapeutics on October 27, 2026, for Compounds For Synthesizing Modified Small Activating Rna Molecules, Modified Small Activating Rna Molecules And Uses Thereof.
Inventors include Zhao, Fulu; Gan, Zubao; Kang, Moorim; and Li, Longcheng.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: Disclosed is a compound having a structure of Formula 1. The compound can be used for synthesizing a modified small activating RNA (saRNA) to enhance gene expression modulation activities of saRNA both in vitro and in vivo. A pharmaceutical composition comprising the compound and a m...